Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement in Grip Strength Following Percutaneous Needle Aponeurotomy for Dupuytren's Disease: A Prospective Clinical Study.

Hand (New York, N.Y.)·2026
Same author

Corrigendum to "Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren"[eClinical Medicine 91(2026); 103714].

EClinicalMedicine·2026
Same author

Determining the comparative pharmacodynamic equivalence of a non-invasive diagnostic test for patients with adrenal insufficiency using a randomised 2-way crossover trial: the STARLIT-3 study protocol.

BMJ open·2026
Same author

Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren.

EClinicalMedicine·2026
Same author

Evaluation of Vapocoolant Spray Before Local Anesthetic Infiltration During Percutaneous Needle Aponeurotomy: A Randomized Controlled Trial.

The Journal of hand surgery·2026
Same author

Efficacy and Tolerability of Metyrapone in Mild Autonomous Cortisol Secretion: Real-World Findings From Clinical Practice.

Clinical endocrinology·2025
Same journal

Transition in Pediatric and Adolescent Hypogonadal Girls: Gynecological Aspects, Estrogen Replacement Therapy, and Contraception.

Endocrine development·2018
Same journal

Transition of Care from Childhood to Adulthood: Congenital Hypogonadotropic Hypogonadism.

Endocrine development·2018
Same journal

Management of Hypothalamic Obesity during Transition from Childhood to Adulthood.

Endocrine development·2018
Same journal

Fertility Preservation in Endocrine Disorders during Transition for Girls.

Endocrine development·2018
Same journal

Transition of Care from Childhood to Adulthood: Turner Syndrome.

Endocrine development·2018
Same journal

Transitions in Care from Pediatric to Adult Health Care Providers: Ongoing Challenges and Opportunities for Young Persons with Diabetes.

Endocrine development·2018
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

Optimal glucocorticoid therapy.

Miguel Debono, Richard J Ross

    Endocrine Development
    |December 18, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Mimicking the body's natural cortisol rhythm with circadian hydrocortisone replacement may improve health. This approach shows promise for patients with adrenal insufficiency, potentially enhancing their quality of life.

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
    08:02

    Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

    Published on: April 25, 2016

    Area of Science:

    • Endocrinology
    • Chronobiology
    • Physiology

    Background:

    • The body's central clock in the suprachiasmatic nucleus regulates physiological rhythms, with peripheral clocks synchronized to it.
    • Cortisol rhythm is a key secondary messenger controlling peripheral clocks; its loss is linked to sleep, mood, and metabolic disorders.
    • Current glucocorticoid replacement fails to replicate normal circadian cortisol patterns in adrenal insufficiency, leading to poor outcomes.

    Purpose of the Study:

    • To investigate the impact of circadian hydrocortisone replacement on quality of life in patients with adrenal insufficiency.
    • To determine if simulating natural cortisol rhythms can improve patient health outcomes.

    Main Methods:

    • Utilizing Chronocort, a modified-release hydrocortisone preparation designed to mimic natural cortisol release patterns.
    • Conducting preliminary studies in patients with congenital adrenal hyperplasia to assess effects on hormone levels.

    Main Results:

    • Demonstrated the ability of Chronocort to simulate the physiological overnight rise in cortisol.
    • Observed control of morning androgen levels in preliminary studies involving patients with congenital adrenal hyperplasia.

    Conclusions:

    • Circadian hydrocortisone replacement, using Chronocort, can effectively simulate natural cortisol rhythms.
    • Further research is necessary to confirm if Chronocort improves quality of life for individuals with adrenal insufficiency.